Last reviewed · How we verify
NCT03067402: ROSSTAR
Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline
NA trial testing Observation in Coronary Heart Disease in 1,100 participants. Status unknown.
20 June 2021
Quick facts
| Lead sponsor | Sir Mortimer B. Davis - Jewish General Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 1,100 |
| Start date | 20 March 2017 |
| Primary completion | 20 June 2021 |
| Estimated completion | 10 June 2022 |
Drugs / interventions tested
- Observation
- Nuclear Perfusion Imaging Stress Test
Conditions studied
- Coronary Heart Disease — all drugs for Coronary Heart Disease →
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Who can join
18 and older, any sex, with Coronary Heart Disease or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The ROSSTAR trial is a pragmatic trial that will directly compare the strategies of routine and selective stress imaging testing (with radionuclide imaging (RNI)) late after PCI or CABG in asymptomatic patients. The study will be a single center trial based at the Jewish General Hospital (JGH), a McGill University teaching hospital (Montreal, Quebec). A total of 1100 patients who are either \>5 years post-CABG or \>2 years post-PCI will be randomized. Half of the patients will be randomized to a routine RNI testing, and the other half to selective RNI testing.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03067402
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observation
Trials testing the same drug.
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
- NCT07563088 — SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · not yet recruiting
- NCT07513324 — Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · Phase 2 · not yet recruiting
- NCT07457099 — Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral a · not yet recruiting
- NCT07472478 — Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12 · Phase 2 · not yet recruiting
Other recruiting trials for Coronary Heart Disease
Currently open trials in the same condition.
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
- NCT07110415 — Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by · Phase 4 · recruiting
- NCT07451873 — Glycocalyx and Oxidative Stress in Endothelial Function (Part 2) · recruiting
- NCT07118930 — Study of Sivelestat Sodium in OPCABG · Phase 2 · recruiting
Other Sir Mortimer B. Davis - Jewish General Hospital trials
Trials by the same sponsor.
- NCT07371728 — Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery · Phase 4 · not yet recruiting
- NCT07254962 — CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE) · Phase 2 · not yet recruiting
- NCT07003880 — Penthrox in Otolaryngology · not yet recruiting
- NCT06888388 — Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast · recruiting
- NCT06530524 — Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03067402 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sir Mortimer B. Davis - Jewish General Hospital
- Last refreshed: 16 March 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03067402.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing